Safety, Tolerability, and Pharmacokinetics of PA9159 Nasal Spray in Healthy Adult Subjects
Clinical trial NCT05170763 · COMPLETED
Trial details
- NCT number
- NCT05170763
- Sponsor
- Anhui Palo Alto Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2022-01-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.